The function of urokinase and its receptor is essential for cell migration in pathological conditions, as shown by the analysis of knockout mice phenotypes. How a protease of a fibrinolytic pathway can induce migration is not understood and no link between this protease and migration-promoting G protein-coupled receptors has been described. We now show that FPRL1͞LXA4R, a G protein-coupled receptor for a number of polypeptides and for the endogenous lipoxin A4 (LXA4), is the link between urokinase-type plasminogen activator (uPA) and migration as it directly interacts with an activated, soluble, cleaved form of uPA receptor (uPAR) (D2D3 88 -274) to induce chemotaxis. In this article we show that (i) both uPAR and FPRL1͞LXA4R are necessary for the chemotactic activity of uPA whereas FPRL1͞LXA4R is sufficient to mediate D2D388-274-induced cell migration. (ii) Inhibition or desensitization of FPRL1͞LXA4R by antibodies or specific ligands specifically prevents chemotaxis induced by D2D388-274 in THP-1 cells and human peripheral blood monocytes. (iii) Desensitization of FPRL1͞ LXA4R prevents the activation of tyrosine kinase Hck induced by D2D3 88 -274. (iv) D2D388-274 directly binds to FPRL1͞LXA4R and is competed by two specific FPRL1͞LXA4R agonists, the synthetic MMK-1 peptide and a stable analog of LXA4. Thus, a naturally produced cleaved form of uPAR is a unique endogenous chemotactic agonist for FPRL1͞LXA4R receptor and its activity can be antagonized by specific ligands. These results provide the first direct link, to our knowledge, between the fibrinolytic machinery and the inflammatory response, demonstrating that uPA-derived peptide fragments can activate a specific chemotactic receptor. U rokinase plasminogen activator (uPA) is a serine protease that activates plasminogen (Plg) to plasmin and binds to a specific high affinity cell surface receptor, uPAR (CD87) (1). The phenotype of uPA Ϫ/Ϫ and uPAR Ϫ/Ϫ mice is not caused only by the lack of Plg activation. Indeed, Plg Ϫ/Ϫ mice die early with multiple thrombosis and extensive fibrin deposits, whereas the uPA Ϫ/Ϫ and uPAR Ϫ/Ϫ mice live normally, showing rare thrombotic events and occasional fibrin deposits (2). Lack of uPA, however, causes impaired migration of lymphocytes and macrophages to tissue lesions, with impairment of the host defenses, bacterial spreading, and death (3), or resistance to the development of aneurysms in a mouse model (2). Deficient recruitment of peritoneal or lung neutrophils at inflammatory sites in Pseudomonas aeruginosa infection and deficient Mac-1 function in macrophages and neutrophils is also observed in uPARdeficient mice (4, 5).uPA binding to uPAR induces intracellular signaling affecting cell adhesion, migration, and proliferation. uPA binding to uPAR induces chemotaxis in a variety of cells, with activation of tyrosine kinases (Hck, Src), MEK, c-Raf, Tyk-3, PI-3-K, and Rac (1, 5-7).uPAR is a high affinity cell surface receptor for uPA (1), formed by three extracellular domains (D1, D2, and D3), and anchored to the plasma m...
Summary. Concentrations of ( + )and ( \ m=-\ ) gossypol were measured by high performance liquid chromatography after they were incubated with plasma proteins in vitro. The concentration of ( \m=-\) gossypol decreased more than the concentration of ( + ) gossypol. A similar decrease in free gossypol concentrations in the blood plasma of rats was observed after intravenous infusion of gossypol enantiomers. The concentration of ( \ m=-\ ) gossypol was also found to be lower than the concentration of ( + ) gossypol at the blood\p=n-\testisbarrier. The biological effect of ( \ m=-\ ) gossypol probably results from its stereospecific binding to extra-and intracellular proteins in vivo and inhibition of the biological activity of some proteins.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.